COCAINE HYDROCHLORIDE
| Brand name | NUMBRINO |
|---|---|
| Active ingredient | COCAINE HYDROCHLORIDE |
| Strength | 4% |
| Dosage form | SOLUTION |
| Route | NASAL |
| Modality | Small molecule |
| FDA approval | January 2020 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 10973811 | February 2037 | use U-3680 |
| 10894012 | February 2037 | use U-3014 |
| 10857095 | February 2037 | use U-3014 |
| 10420760 | February 2037 | use U-2478 |
| 10413505 | February 2037 | use U-3014 |
| 10149843 | February 2037 | use U-2479 |
| 10016407 | February 2037 | use U-2329 |
| 9867815 | February 2037 | use U-2226 |
| 10933060 | February 2037 | use U-3014 |
| 11040032 | February 2037 | product |
| 10231961 | February 2037 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.